🇺🇸
United States · US · US:50090-6439_68a9b7e3-8bf4-4e52-a853-9b30b906e314
REZVOGLAR KWIKPEN
In shortageUNIISPLATC A10AE04
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerA-S Medication Solutions
CountryUS (United States)
ATC codeA10AE04
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1150090643905 SYRINGE in 1 CARTON (50090-6439-0) / 3 mL in 1 SYRINGE
Annotations
UNII (FDA Substance ID)
2ZM8CX04RZ
INSULIN GLARGINE
RxCUI 274783
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension
Raw payload (JSON)
{
"unii": {
"unii": "2ZM8CX04RZ",
"rxcui": "274783",
"inchikey": null,
"display_name": "INSULIN GLARGINE",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"f6af8706-2058-4fe1-99c8-43684c20bfa2": {
"match": "brand_token",
"title": "REZVOGLAR KWIKPEN (INSULIN GLARGINE-AGLR) INJECTION, SOLUTION [ELI LILLY AND COMPANY]",
"spl_version": "7",
"published_date": "2024-08-19"
}
},
"productid": "50090-6439_68a9b7e3-8bf4-4e52-a853-9b30b906e314",
"productndc": "50090-6439",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "INSULIN GLARGINE",
"shortage_reason": "Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension",
"shortage_status": "current",
"proprietary_name": "REZVOGLAR KWIKPEN",
"active_ingred_unit": "[iU]/mL",
"application_number": "BLA761215",
"marketing_category": "BLA",
"nonproprietary_name": "Insulin glargine-aglr",
"start_marketing_date": "20211217",
"active_numerator_strength": "100"
}Related drugs
Other records sharing ATC code A10AE04.
Access this data programmatically
Query REZVOGLAR KWIKPEN and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.